TY - JOUR
T1 - Estimation of Excess Deaths Associated with the COVID-19 Pandemic in the United States, March to May 2020
AU - Weinberger, Daniel M.
AU - Chen, Jenny
AU - Cohen, Ted
AU - Crawford, Forrest W.
AU - Mostashari, Farzad
AU - Olson, Don
AU - Pitzer, Virginia E.
AU - Reich, Nicholas G.
AU - Russi, Marcus
AU - Simonsen, Lone
AU - Watkins, Anne
AU - Viboud, Cecile
N1 - Funding Information:
Funding/Support: This study was supported by grants R01AI123208 (Dr Weinberger), R01AI137093 (Drs Weinberger and Pitzer), R01AI112970 (Dr Pitzer), and R01AI146555 (Dr Cohen) from the National Institute of Allergy and Infectious Diseases/National Institutes of Health; by grant 1DP2HD091799-01 (Dr Crawford) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development; by grant R35GM119582 (Dr Reich) from the National Institute of General Medical Sciences/National Institutes of Health; by grant 1U01IP001122 (Dr Reich) from the CDC; and by grant CF20-0046 (Dr Simonsen) from the Carlsberg Foundation.
Funding Information:
reported receipt of consulting fees from Pfizer, Merck, GlaxoSmithKline, and Affinivax for topics unrelated to this work and being principal investigator on a research grant from Pfizer on an unrelated topic. Dr Pitzer reported having received reimbursement from Merck and Pfizer for travel expenses to scientific input engagements unrelated to the topic of this work and being a member of the World Health Organization Immunization and Vaccine-related Implementation Research Advisory
Publisher Copyright:
© 2020 American Medical Association. All rights reserved.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Importance: Efforts to track the severity and public health impact of coronavirus disease 2019 (COVID-19) in the United States have been hampered by state-level differences in diagnostic test availability, differing strategies for prioritization of individuals for testing, and delays between testing and reporting. Evaluating unexplained increases in deaths due to all causes or attributed to nonspecific outcomes, such as pneumonia and influenza, can provide a more complete picture of the burden of COVID-19. Objective: To estimate the burden of all deaths related to COVID-19 in the United States from March to May 2020. Design, Setting, and Population: This observational study evaluated the numbers of US deaths from any cause and deaths from pneumonia, influenza, and/or COVID-19 from March 1 through May 30, 2020, using public data of the entire US population from the National Center for Health Statistics (NCHS). These numbers were compared with those from the same period of previous years. All data analyzed were accessed on June 12, 2020. Main Outcomes and Measures: Increases in weekly deaths due to any cause or deaths due to pneumonia/influenza/COVID-19 above a baseline, which was adjusted for time of year, influenza activity, and reporting delays. These estimates were compared with reported deaths attributed to COVID-19 and with testing data. Results: There were approximately 781000 total deaths in the United States from March 1 to May 30, 2020, representing 122300 (95% prediction interval, 116800-127000) more deaths than would typically be expected at that time of year. There were 95235 reported deaths officially attributed to COVID-19 from March 1 to May 30, 2020. The number of excess all-cause deaths was 28% higher than the official tally of COVID-19-reported deaths during that period. In several states, these deaths occurred before increases in the availability of COVID-19 diagnostic tests and were not counted in official COVID-19 death records. There was substantial variability between states in the difference between official COVID-19 deaths and the estimated burden of excess deaths. Conclusions and Relevance: Excess deaths provide an estimate of the full COVID-19 burden and indicate that official tallies likely undercount deaths due to the virus. The mortality burden and the completeness of the tallies vary markedly between states.
AB - Importance: Efforts to track the severity and public health impact of coronavirus disease 2019 (COVID-19) in the United States have been hampered by state-level differences in diagnostic test availability, differing strategies for prioritization of individuals for testing, and delays between testing and reporting. Evaluating unexplained increases in deaths due to all causes or attributed to nonspecific outcomes, such as pneumonia and influenza, can provide a more complete picture of the burden of COVID-19. Objective: To estimate the burden of all deaths related to COVID-19 in the United States from March to May 2020. Design, Setting, and Population: This observational study evaluated the numbers of US deaths from any cause and deaths from pneumonia, influenza, and/or COVID-19 from March 1 through May 30, 2020, using public data of the entire US population from the National Center for Health Statistics (NCHS). These numbers were compared with those from the same period of previous years. All data analyzed were accessed on June 12, 2020. Main Outcomes and Measures: Increases in weekly deaths due to any cause or deaths due to pneumonia/influenza/COVID-19 above a baseline, which was adjusted for time of year, influenza activity, and reporting delays. These estimates were compared with reported deaths attributed to COVID-19 and with testing data. Results: There were approximately 781000 total deaths in the United States from March 1 to May 30, 2020, representing 122300 (95% prediction interval, 116800-127000) more deaths than would typically be expected at that time of year. There were 95235 reported deaths officially attributed to COVID-19 from March 1 to May 30, 2020. The number of excess all-cause deaths was 28% higher than the official tally of COVID-19-reported deaths during that period. In several states, these deaths occurred before increases in the availability of COVID-19 diagnostic tests and were not counted in official COVID-19 death records. There was substantial variability between states in the difference between official COVID-19 deaths and the estimated burden of excess deaths. Conclusions and Relevance: Excess deaths provide an estimate of the full COVID-19 burden and indicate that official tallies likely undercount deaths due to the virus. The mortality burden and the completeness of the tallies vary markedly between states.
U2 - 10.1001/jamainternmed.2020.3391
DO - 10.1001/jamainternmed.2020.3391
M3 - Journal article
C2 - 32609310
AN - SCOPUS:85088389654
SN - 2168-6106
VL - 180
SP - 1336
EP - 1344
JO - JAMA Internal Medicine
JF - JAMA Internal Medicine
IS - 10
ER -